Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Summary

This research study is studying a drug as a possible treatment for advanced myeloid malignancies including AML (acute myeloid leukemia), MDS (myelodysplastic syndrome) and MPN (myeloproliferative neoplasms) The intervention involved in this study is: -Regorafenib (Stivarga)

Timeline

Start

2017-04-17

Primary completion

2021-09-01

Completion

2023-02-27

Drugs

Indications